Back to top

Astria Therapeutics (ATXS) Receives a Buy from Jefferies

In a report released today, from Jefferies maintained a Buy rating on Astria Therapeutics, with a price target of $30.00. The company’s shares clos...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Astria Therapeutics, Inc. (ATXS)